Dr. Abdulaziz Almalik is the Director-General for Research and Innovation Support at King Abdulaziz City for Science and Technology (KACST) in Saudi Arabia, since 2021. He has also served as Vice President for Scientific Research Support and Director of Life Sciences and Environmental Research Institute (LSERI) at KACST.
Dr. Almalik is serving as the Chairman of the National Committee of Bioethics (NCBE), since 2019, a Member of the National Committee for Education Culture and Science since 2021, a Member of the Board of Directors of the Saudi Institute for Health Research (Saudi NIH), since 2021, the Chairman of Almarai Prize for Scientific Innovation Secretariat Committee, since 2020, and a Member of the Advisory Committee for the Health Research Program (Health Transformation Program and the Model of Care), since 2021. He has also served as a Member of the Board of Directors of the Saudi Authority for Intellectual Property, a Member of the Steering Committee of Science 20 Saudi Arabia G20 2020 Presidency and Vice-Chairman and a Member of KACST Scientific Council. He has worked on multiple strategy development objectives and contributed to the successful execution of a plethora of national research, development and innovation programs.
Dr. Almalik is a Research Professor of Pharmaceutical Sciences. He received his PhD degree in Pharmaceutical Sciences from the University of Manchester in 2013, obtained his MSc with merit in Clinical Pharmacology from the University of Glasgow in 2008, and received his Bachelor degree in Pharmaceutical Sciences (B.Pharm.) from King Saud University in 2005. His research interest is focused on the design and development of novel tunable delivery platforms and polymer-based nanodevices for therapeutic and diagnostic applications. Throughout his scientific career, Dr. Almalik accumulated extensive knowledge and practical experience in intellectual property generation, acquisition and management backed by strong academic credentials and recognized by many bodies for R&D excellence, holding over 40 publications in leading scientific journals and several patents.
All rights reserved for IPA © 2022